Pancreatic islets adapt to insulin resistance of pregnancy by up regulating β-cell proliferation and increase insulin secretion. Previously, we found that prolactin receptor (Prlr) signaling is important for this process, as heterozygous prolactin receptor-null (Prlr +/-) mice are glucose intolerant, had a lower number of β cells and lower serum insulin levels than wild type mice during pregnancy. However, since Prlr expression is ubiquitous, to determine its β-cell specific effects, we generated a transgenic mouse with a floxed Prlr allele under the control of an inducible promoter, allowing conditional deletion of Prlr from β cells in adult mice. In this study, we found that β-cell-specific Prlr reduction resulted in elevated blood glucose during pregnancy. Similar to our previous finding in mouse with global Prlr reduction, β-cell-specific Prlr loss led to a lower β-cell mass and a lower in vivo insulin level during pregnancy. However, these islets do not have an intrinsic insulin secretion defect when tested in vitro. Interestingly, when we compared the islet gene expression profile, using islets isolated from mice with global versus β-cell-specific Prlr reduction, we found some important differences in genes that regulate apoptosis and insulin secretion. This suggests that Prlr has both cell-autonomous and non-cell-autonomous effect on β cells, beyond its regulation of pro-proliferative genes.
Introduction
Pregnancy is characterized by insulin resistance to shunt nutrients from the mother to the developing fetus. Pancreatic β cells adapt to the insulin resistance of pregnancy by up regulating islet mass and insulin secretion, a process that quickly reverses at parturition (25, 31) . In animal studies, pregnancyinduced β-cell adaptation consists of 1) a lower threshold for glucose-stimulated insulin secretion, 2) a higher insulin content, and 3) a higher β-cell proliferation rate (5, 22, 23, 30, 33) . Both in vitro and in vivo observations support a role for prolactin (PRL) and/or placental lactogens (PLs) in this adaptive process. First, prolactin receptor (Prlr), the receptor for both PRL and PLs, is present on pancreatic β cells and Prlr expression increases during pregnancy (1, 9, 17, 19, 32) . Second, the rise in PRL and PLs levels parallel the increases in β-cell mass and glucose-stimulated insulin secretion during pregnancy (29) . Third, in vitro exposure of isolated islets to PRL/PLs increases insulin secretion, β-cell proliferation and lowers the threshold of glucose-stimulated insulin secretion (6, 7, 32) , mimicking the effects of pregnancy on β cells. To determine whether Prlr signaling is required for β-cell adaptation to pregnancy in vivo, transgenic mice with global or β-cell specific Prlr knockout have been examined.
Using heterozygous prolactin receptor-null mice (Prlr +/-), we confirmed the in vivo role of Prlr on βcell adaptation to pregnancy (12) . We found that in comparison to their wild type littermates, pregnant Prlr +/dams were glucose intolerant and secreted less insulin in response to an intraperitoneal glucose tolerance test (IPGTT). They also had a lower β-cell proliferation rate and lower β-cell mass than the Prlr +/+ mice. We could not use the homozygous Prlr -/mice because they have a placental implantation defect, thus are infertile. Two separate groups have since generated β-cell specific Prlr-knockout mice, one using the rat insulin promoter controlled Cre (i.e. RIP-Cre) and the other using the Pdx1 promoter controlled Cre (i.e. Pdx1-Cre) (3, 20, 24) . Similar to our findings in Prlr +/mice, β-cell specific Prlrdeletion caused gestational diabetes, accompanied by a reduction in β-cell proliferation and a blunted glucose-stimulated insulin secretion. However, since both the insulin promoter and the Pdx1 promoter by sampling from tail vein at 8am, and at the same time, an additional 30µl of serum was taken from the saphenous vein and stored at -80ºC for later measurement of insulin by ELISA.
Materials.
Collagenase P (Ref#11 213 865 001), trypsin 1mg tablets (T7168) and all chemicals are from Sigma.
Sources of antibodies are specified below.
Immunostaining.
Pancreas was isolated from pregnant and non-pregnant mice, weighed, embedded in paraffin blocks, longitudinally serial sectioned to 7 µm then stained for insulin to identify β cells as previously described (12) . Briefly, after 1 hour of blocking with 1% goat serum/PBS at room temperature, tissues were incubated with primary antibody over night at 4°C (guinea pig anti-insulin at 1:750, DAKO; diluted in 1% goat serum/PBS). This was followed by 1-hour incubation with fluorophore-conjugated secondary antibodies (Cy3-anti-guinea pig, Jackson Laboratories, diluted in 1% goat serum/PBS at 1:300). Bis-benzimide H 33342 trihydrochloride (0.1µg/ml, Sigma) was added to the secondary antibody for nuclear staining. Stained sections were mounted using DakoCytomation fluorescent mounting medium and stored at 4°C.
Islet Morphometry.
Consecutive images of non-overlapping, adjacent areas of the entire pancreas section were acquired using a Zeiss fluorescence microscope, and captured with a CoolSnap digital camera (12) . Images were analyzed by ImageJ software to measure the insulin-positive area as well as the area of the entire pancreas section (identified by nuclear staining). β-cell mass was calculated by multiplying the pancreas weight by the β-cell fraction (i.e. the ratio of insulin-positive cell area to total pancreatic tissue area on the entire section. Results represent the average of 6-8 tissue sections per animal from 5-6 animals from each genotype.
Islet Isolation.
The pancreas was first distended using collagenase P (0.66mg/ml in Hank's Balanced Salt Solution, 2.5ml/pancreas), surgically removed and then incubated at 37°C for 15min under constant agitation.
Islets were hand-picked and cultured overnight in RPMI1640 supplemented with 10% fetal bovine serum and penicillin/streptomycin (11) .
Islet RNA isolation and quantitative real-time RT-PCR.
Total islet RNA (100-200 islets/mouse) was extracted using the RNeasy Mini Kit (Qiagen). RNA concentration and integrity were assessed using the ND-1000 Spectrophotometer (NanoDrop). cDNA was synthesized using the Quantitect Reverse Transcription Kit (Qiagen). Reactions were carried out in triplicate with QuantiFast SYBR Green Master Mix (Qiagen) at an annealing temperature of 60ºC. Data were collected using the DNA Engine Opticon2 Continuous Fluorescence Detection System (BioRad) and software (Bio-Rad). Primer identifying both long and short forms of prolactin receptor was designed using Primer Designing Software (NCBI); sequence: Forward: 5'
ATCTTTCCACCAGTTCCGGG, and Reverse: 5' TTGGAGAGCCAGTCT CTAGC. The primer sequence for estrogen receptor 1 (ESR 1) is: Forward: TCTGCCAAGGAGACTCGCTACT, and Reverse: 5' GGTGCATTGGTTTGTAGC TGGAC. The relative amount of RNA was determined by comparison with phosphoglycerate kinase 1 (Pgk1) mRNA as a reference gene as previously described (11) .
RNAseq analysis.
Total RNA (100-200 islets/mouse) was extracted using the RNeasy Mini Kit (Qiagen 
Statistical analysis.
All statistics were performed using GraphPad Prism 4 software. Two-tailed Student's t tests or ANOVA with Bonferroni post-tests were performed where appropriate. Comparisons were made between the homozygous conditional knockout (βPrlR fl/fl ), the heterozygous conditional knockout (βPrlR fl/+ ), the wild type littermate (βPrlR +/+ ), or the Prlr +/mice, as stated in the Figure Legend .
Results

Generation of inducible, pancreas-specific prolactin receptor deleted transgenic mice
To understand the role of prolactin receptor signaling on pancreatic β-cell mass and function during pregnancy, we generated mice harboring an inducible conditional deletion of Prlr from the pancreas.
We interbred the Pdx1CreER TM mouse, which has a tamoxifen- Figure) . To induce Cre recombinase expression, mice were given tamoxifen at age 8-10 weeks. We found that in comparison to control littermate without the floxed Prlr allele, i.e. the βPrlr +/+ mice, βPrlR fl/+ mice had a ~40% reduction in prolactin receptor expression in isolated islets ( Fig. 1) . In comparison to their respective wild type littermates, we found similar magnitude of reduction in prolactin receptor expression in the islets of βPrlR fl/+ and Prlr +/mice, the latter are transgenic mice with global heterozygous prolactin receptor deletion (12) . The reduction in prolactin receptor is specific to the pancreatic islets, as we observed no significant reduction in the prolactin receptor expression in the hypothalamus, fat, and liver ( Fig. 1) , Fig. 2a-b ). There is no significant difference in fasting blood glucose, but random non-fasted blood glucose is higher in the βPrlR fl/+ mice (8.14±0.29mM vs. 7.0±0.30mM for βPrlr +/+ mice, n=10-16)( Fig. 2c-d) . Interestingly, the βPrlR fl/fl mice, which has a 90% reduction in prolactin receptor expression, has a similar degree of glucose intolerance as the βPrlR fl/+ mice (Fig. 2) . As expected, there is no difference in insulin tolerance between the wild type and mutants ( Fig. 2e) , as prolactin receptor is only deleted from the pancreatic islets and not from other insulin responsive tissues, such as liver and fat ( Fig. 1) .
βPrlR fl/+ mice had lower β-cell mass and secreted less insulin Similar to our previous observation in the heterozygous global Prlr-deletion mice (Prlr +/-)(12), βPrlR fl/+ mice had a lower β-cell mass than their wild type littermates on day 15 of pregnancy ( Fig. 3) . During an IPGTT, βPrlR fl/+ secreted less insulin (expressed as integrated area under the curve)( Fig. 4) .
Interestingly, the βPrlR fl/+ mice had slightly higher fasting insulin, although there is a very wide variability. To determine whether the blunted in vivo insulin secretion is due to a decrease in β-cell mass or the islets are less able to respond to glucose, we performed in vitro glucose-stimulated insulin secretion test. Here, we found that islets from βPrlR +/+ and βPrlR fl/+ mice were equally responsive to glucose, suggesting that the difference in in vivo insulin secretion was a result of the smaller β-cell mass of the βPrlR fl/+ mice.
Prolactin receptor has non-cell autonomous effects on β-cell gene expression during pregnancy
The above results demonstrated that transgenic mice with global (Prlr +/-) or β-cell specific prolactin receptor deletion (βPrlR fl/+ ) are phenotypically similar: both are glucose intolerant on day 15 of pregnancy, with lower β-cell mass and secreted less insulin in response to glucose, in comparison to their wild type littermates. However, since prolactin receptor is ubiquitously expressed, including on the endothelial and epithelial cells in islets, we want to compare the gene expression profile of islets from βPrlR fl/+ to that of the Prlr +/mice, to determine whether a reduction in Prlr in non-β cells can secondarily affect β-cell gene expression. We performed RNAseq analysis and found that estrogen receptor 1 expression was lower in the Prlr +/islets in comparison to βPrlR fl/+ islets ( Fig 5) . Ingenuity pathway analysis found several canonical pathways that are differentially expressed, including the serotonin receptor-signaling pathway, which has been previously found to regulate β-cell proliferation during pregnancy (13) .
Discussion
Pregnancy is an insulin resistant state and maternal pancreatic islets adapt to the increase in insulin demand by up regulating β-cell proliferation and increase insulin secretion. Previously, we have shown that a transgenic mouse with global, heterozygous deletion of prolactin receptor (Prlr +/-) was glucose intolerant during pregnancy. This was accompanied by a reduction in β-cell proliferation, βcell mass, and a blunted glucose-stimulated insulin secretion in comparison to their wild type littermates (12) . A caveat of using a global knockout mouse is that the ubiquitous expression of prolactin receptor raises the possibility that the phenotype observed in the pancreatic islet is secondary to prolactin action in tissues other than β cells. To address this possibility, we generated a transgenic mouse with an inducible, conditional prolactin receptor gene knockout. We chose to make the gene deletion inducible because β-cell specific promoters such as the insulin promoter or the Pdx1 promoter are expressed during embryonic development of the pancreas (26) . In fact, Auffret et al found that transgenic mouse with a global, homozygous deletion of prolactin receptor (i.e. Prlr -/-) has abnormal βcell mass expansion both embryonically and during perinatal life (2) . They found a 30% reduction in β-cell mass in the Prlr -/newborns. Hence, an inducible gene deletion during adulthood would circumvent this developmental defect and allow us to study prolactin receptor effect specifically during pregnancy.
Several groups have since generated conditional knockout of the prolactin receptor gene. subunits, Suz12 and enhancer of zeste homolog 2 are Prlr signaling targets (24) . Interestingly, Prlr was not required for β-cell adaptation to high fat feeding. In fact, pregnancy and high fat feeding activate very different genes in the islets, suggesting that the two metabolic stressors engage different mechanisms to adapt. Interestingly, RIP-Cre is expressed in the arcuate nucleus (28) and Prlr has been specifically deleted from the arcuate nucleus but the effect on glucose homeostasis was not reported (8) .
Nteeba et al also generated a β-cell-specific Prlr knockout mouse, using a Pdx1-Cre promoter (20) .
Consistent with Banerjee et al., they found glucose intolerance during second pregnancy. Interestingly, the β-cell-specific Prlr knockout mice had lower β-cell mass in non-pregnant state and the pregnancystimulated β-cell mass expansion was essentially non-existent in their model. Moreover, they found that the loss of maternal pancreatic Prlr-signaling was association with a reduction in body weight of the offspring, at embryonic day 15 and on day 1 after delivery. There is also significant dysregulation of placental prolactin family of genes.
Prolactin receptor expression is ubiquitous, and it is expressed on the endothelial cells and ductal cells in the islets. To identify potential non-autonomous effect of Prlr on β cells, we performed RNAseq analysis, comparing gene expression of islets from Prlr +/vs. βPrlR fl/+ mice on day 15 of pregnancy. There is a reduction in estrogen receptor 1 (ESR1) expression in the Prlr +/mice; this is interesting because estrogen receptor protect β cells from apoptosis (15) . Our previous observation that islets from Prlr +/mice are more sensitive to free fatty acid induced apoptosis than islets from Prlr +/+ mice (16) may be in part attributable to this down regulation of ESR1 in islets of Prlr +/mice. Another interesting finding from our RNAseq analysis is that Ingenuity pathway analysis identified serotonin receptor signaling as one of the top canonical pathway that is differentially regulated between Prlr +/and βPrlR fl/+ mice (13, 21) . Kim et al previously reported that serotonin acts downstream of Prlr signaling to stimulate β-cell proliferation, and this was through the Gaq-linked serotonin receptor 5hydroxytryptamine receptor -2b (Htr2b) (13) . In a subsequent study, they found that another serotonin receptor, Htr3a is important for regulation of insulin secretion (14) . Taken together, the results from the 
